DEC 26, 2017 07:57 AM PST

Nourishing Immune Cells in the Uterus Promote Early Fetal Growth

WRITTEN BY: Kara Marker

Immune cells in the uterus that produce important growth-promoting factors could be both the explanation for and the solution to recurrent spontaneous abortions affecting pregnant women worldwide. In a new study published in the journal Immunity, scientists explore natural killer cells in the uterus.

An artistic representation of how decidual NK cells promote fetal growth during early pregnancy. Credit: Binqing Fu

Natural killer (NK) cells are some of the most plentiful cells in the uterus during pregnancy, but only during the first trimester; the NK cell population decreases after formation of the placenta. However, while NK cells remain abundant, a specific subset of these cells plays the vital role of producing pleiotrophin and osteoglycin, growth-promoting factors found in both humans and mice.

Co-senior author Haimin Wei praises the study for both identifying new characteristics of natural killer cells in the context of pregnancy and for highlighting “approaches for therapeutic administration of natural killer cells in order to reverse restricted nourishment within the uterine microenvironment.”

Pregnant women with a smaller-than-normal population of pleiotrophin- and osteoglycin-producing NK cells in the uterine lining were found to be more likely to experience recurrent spontaneous abortion, also known as recurrent miscarriage, habitual abortion, or recurrent pregnancy loss; it occurs in about 15 percent of all “clinically recognized” pregnancies. This condition is thought to happen due to what Wei calls “restricted” fetal development as a result of missing growth-promoting factors from NK cells.

Wei and other researchers also found that supplying pregnant mice with these NK cells could reverse damage done to fetal development as a result of deficient amounts of pleiotrophin and osteoglycin. As a clinical application, medical professionals could potentially transfer natural killer cells via intravenous infusion or the administration of a vaginal suppository, Wei says - no need for invasive procedures with pregnant women.

Going forward, Wei and his team have yet to determine whether pleiotrophin, osteoglycin, and other growth-promoting factors impact fetal development directly, via the maternal-fetal barrier, or indirectly, via support of placenta and blood vessel growth.

"This study provides an avenue for treating fetal growth restriction, recurrent spontaneous abortion with unknown reasons, and age-related fetal loss by improving the uterus microenvironment,” concluded co-senior author Zhigang Tian.

Sources: Reviews in Obstetrics & Gynecology, Cell Press

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 23, 2018
Immunology
JUL 23, 2018
Obesity Associated Inflammation Leads to Chronic Health Issues
Inflammation caused by harmful oxidized lipids increases in individuals with obesity and may contribute to chronic disease development....
AUG 25, 2018
Immunology
AUG 25, 2018
Maternal Depression Alters Mom and Baby's Immune Markers
Maternal depression alters stress and immune system biomarkers in children leading to social withdrawal and behavioral problems....
AUG 29, 2018
Immunology
AUG 29, 2018
Artificial Intelligence Predicts Response to Immunotherapy
Artificial intelligence can process CT scan images to determine biological and clinical information that can predict immunotherapy efficacy thanks to machine learning....
SEP 22, 2018
Immunology
SEP 22, 2018
Could Diet Protect Against Brain Inflammation?
Immune brain cell inflammation due to aging can be mitigated through a high fiber diet...
OCT 10, 2018
Microbiology
OCT 10, 2018
It's Time for Your Annual Flu Shot
After last year's flu season killed around 80,000 people, the CDC is trying to get the word out about the flu vaccine....
OCT 31, 2018
Drug Discovery
OCT 31, 2018
New Drug Target For a Rare Lymphoma
The promise of immunotherapy in oncology is stronger than ever. Now, an international team of scientists and physicians from the Research Institute of the ...
Loading Comments...